Cancer chemotherapy with indole-3-carbinol, bis(3′-indolyl)methane and synthetic analogs

被引:248
|
作者
Safe, Stephen [1 ,2 ]
Papineni, Sabitha [1 ,2 ]
Chintharlapalli, Sudhakar [2 ]
机构
[1] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA
[2] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
I3C; DIMs; Anticarcinogenesis; Nur77; PPAR;
D O I
10.1016/j.canlet.2008.04.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Indole-3-carbinol (I3C) conjugates are phytochemicals expressed in brassica. vegetables and have been associated with the anticancer activities of vegetable consumption. I3C and its metabolite bis(3'-indolyl)methane (DIM) induce overlapping and unique responses in multiple cancer cell lines and tumors, and these include growth inhibition, apoptosis and antiangiogenic activities. The mechanisms of these responses are complex and dependent on cell context. I3C and/or DIM activate or inactivate multiple nuclear receptors, induce endoplasmic reticulum stress, decrease mitochondrial membrane potential, and modulate multiple signaling pathways including kinases. DIM has been used as a template to synthesize a series of 1,1-bis(3'indolyl)-1-(substituted aromatic)methanes (i.e. C-DIMs) which are also cytotoxic to cancer cells and tumors. Some of the effects of C-DlMs resemble those reported for DIM analogs; however, structure-activity studies with the aromatic ring has resulted in generation of highly unique receptor agonists. For example, p-trifluoromethylphenyl, p-t-butylphenyl and p-biphenyl analogs activate peroxisome proliferator-activated receptor gamma (PPAR gamma), and p-methoxyphenyl and p-phenyl compounds activate nerve growth factor-induced-B alpha (NGFI-B alpha, Nur77) orphan nuclear receptor. The effects of C-DIMs on PPAR gamma and Nur77 coupled with their receptor-independent activities has resulted in the development of a novel group of multi-targeted anticancer drugs with excellent potential for clinical treatment of cancer. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:326 / 338
页数:13
相关论文
共 50 条
  • [1] Indole-3-carbinol and prostate cancer
    Sarkar, FH
    Li, YW
    JOURNAL OF NUTRITION, 2004, 134 (12): : 3493S - 3498S
  • [2] Indole-3-carbinol
    不详
    ALTERNATIVE MEDICINE REVIEW, 2005, 10 (04) : 337 - 342
  • [3] INDOLE-3-CARBINOL
    PREOBRAZHENSKAYA, MN
    KOROLEV, AM
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (15): : 1210 - 1211
  • [4] INDOLE-3-CARBINOL : A BOON TO CANCER PATIENT
    Srivastav, Bhawana
    Saxena, Vijay L.
    EVERYMANS SCIENCE, 2012, 47 (02): : 122 - 125
  • [5] Targets for indole-3-carbinol in cancer prevention
    Kim, YS
    Milner, JA
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2005, 16 (02): : 65 - 73
  • [6] Synthesis of Indole-3-carbinol
    Jiangsu Xuzhou Vocational College of Pharmaceutics, Xuzhou 221116, China
    Xiandai Huagong/Modern Chemical Industry, 2008, 28 (06): : 43 - 45
  • [7] INDOLE-3-CARBINOL - RESPONSE
    MICHNOVICZ, JJ
    BRADLOW, HL
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (15): : 1211 - 1212
  • [8] Effects of analogs of indole-3-carbinol cyclic trimerization product in human breast cancer cells
    Xue, L
    Schaldach, CM
    Janosik, T
    Bergman, J
    Bjeldanes, LF
    CHEMICO-BIOLOGICAL INTERACTIONS, 2005, 152 (2-3) : 119 - 129
  • [9] Indole-3-carbinol - A novel approach to breast cancer prevention
    Bradlow, HL
    Sepkovic, DW
    Telang, NT
    Osborne, MP
    CANCER PREVENTION: FROM THE LABORATORY TO THE CLINIC: IMPLICATIONS OF GENETIC, MOLECULAR, AND PREVENTIVE RESEARCH, 1995, 768 : 180 - 200
  • [10] Indole-3-carbinol as a chemoprotective agent in breast and prostate cancer
    Bradlow, H. Leon
    IN VIVO, 2008, 22 (04): : 441 - 445